Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
APLS | Apellis Pharmaceuticals, Inc. | Director | $3.33M | -$5.33M | -61.6% | Sep 23, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|